Skip to main content

Sign In |
Support |
Select your language

Menu

Products
Applications
Resources
About Us
Contact Us

Home
Resources
Publication
Patient specific Long QT syndrome type 3 cardiomyocytes can be used for clinical drug safety assessments

Patient specific Long QT syndrome type 3 cardiomyocytes can be used for clinical drug safety assessments

Bohlen B, and Brugada P.

Arrhythm Electrophysiol Rev., 2019

Related Resources

There are currently no related resources.

Related Products

Maestro Pro Product Image

Maestro Pro

Maestro Edge multiwell MEA system

Maestro Edge

Cardiac Module for Software

Cardiac Module

Stay Up to Date With Our Newsletter:

At Axion BioSystems, our goal is to help you capture the complex biology of your cells. Whether monitoring the kinetics of cellular growth and death or recording the activity of excitable cells; Axion BioSystems' live-cell assay technology can help you record it noninvasively, in real time, and with software tools to make analysis quick and painless.

All products and application data are for research use only and not intended for human diagnostic or therapeutic uses

Useful Links

Products
Applications
Case Studies
Travel Award

Research Areas

Cardiology
Cellular Kinetics
Neurology
Oncology
Virology

Contact Us

Contact
Office Locations
Tech Support
Request Quote
Search

© 2024 Copyright Axion BioSystems, Inc, All Rights Reserved.

Products
Applications
Resources
About Us
Contact Us
Search